Busulfan/Cyclophosphamide Compared with Melphalan as a Conditioning Regimen for Autologous Transplantation of Multiple Myeloma: A Long-Term Assessment.
Shiyuan ZhouYingying ZhaiLingzhi YanXiaolan ShiJingjing ShangDe-Pei WuChengcheng FuSong JinPublished in: Journal of clinical medicine (2023)
MM patients may also benefit from the dose-adjusted BU/CY regimen.